pyrroles has been researched along with Pleural Effusion, Malignant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, S; Dat, le T; Goto, H; Hanibuchi, M; Kakiuchi, S; Kuramoto, T; Nishioka, Y; Sakaguchi, S; Sato, S; Sone, S; Van, TT; Yukishige, S | 1 |
| Hoekman, K; Jorna, AS; Pinedo, HM; Smit, EF; Verheul, HM | 1 |
2 other study(ies) available for pyrroles and Pleural Effusion, Malignant
| Article | Year |
|---|---|
SU6668, a multiple tyrosine kinase inhibitor, inhibits progression of human malignant pleural mesothelioma in an orthotopic model.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Fibroblast Growth Factor 2; Humans; Indoles; Male; Mesothelioma; Mice; Mice, SCID; Neovascularization, Pathologic; Oxindoles; Pleural Effusion, Malignant; Pleural Neoplasms; Propionates; Protein Kinase Inhibitors; Pyrroles; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2012 |
Targeting vascular endothelial growth factor blockade: ascites and pleural effusion formation.
Topics: Angiogenesis Inhibitors; Antibodies; Ascites; Cell Division; Cells, Cultured; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Inhibitors; Humans; Indoles; Lymphokines; Pleural Effusion; Pleural Effusion, Malignant; Protein Isoforms; Protein-Tyrosine Kinases; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Mitogen; Receptors, Vascular Endothelial Growth Factor; Recurrence; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |